Clinical Studies Search

Protocol Search Results


Protocol No. Title
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12
PSCI-18-103 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Rucaparib in combination with Nivolumab versus Placebo as Switch Maintenance Following Response to Front-Line Platinum-Based Chemotherapy in Patients with High-Grade Serous or Endometrioid Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer
PSCI-18-108 The Effects of a Prehabilitation Exercise Program in Adults Receiving a Hematopoietic Stem Cell Transplant
PSCI-18-119 International Myeloma Foundation Study of the Outcomes of Myeloma Patients with t(11;14) Translocation
PSCI-18-127 A Phase III Randomized Trial Comparing Adjuvant MK-3475 (Pembrolizumab) to Standard of Care Observation in Completely Resected Merkel Cell Carcinoma
PSCI-18-142 Randomized Phase II Study of Nivolumab with or without lpilimumab in Patients with Metastatic or Unresectable Sarcoma
PSCI-18-143 Phase II Study of Osimertinib in Advanced NSCLC Patients with Exon 20 Mutations in EGFR
PSCI-18-144 Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
PSCI-19-005 EA9161: A Randomized Phase III Study of the Addition of Venetoclax to Ibrutinib and Obinutuzumab versus Ibrutinib and Obinutuzumab in Untreated Younger Patients with Chronic Lymphocytic Leukemia (CLL)
PSCI-19-049 AGCT1532, Randomized Phase 3 Trial of Accelerated vs Standard BEP Chemotherapy for Patients with Intermediate and Poor-Risk Metastic Germ Cell Tumors
PSHCI-08-065 Biologic Studies of Experimental Anti-Cancer Therapeutics in Human Leukemia Cells